© Reuters. FILE PHOTO: Britain’s Prince Charles and AstraZeneca Chairman Leif Johansson smile during a visit at the AstraZeneca global R&D facility at the Cambridge Biomedical Campus in Cambridge, Britain November 23, 2021. Chris Jackson/Pool via REUTERS
(Reuters) -AstraZeneca said on Tuesday its non-executive chairman Leif Johansson would retire next year following the Anglo-Swedish drugmaker’s annual general meeting, after having served 11 years in the role.
The Swedish businessman, 70, became chairman in 2012, around the same time Chief Executive Officer Pascal Soriot took charge. Soriot in an interview with the Financial Times last May indicated that succession planning had begun for him and Johansson.
The company said on Tuesday the search for a chair successor was “proceeding well.”
Last year, AstraZeneca (NASDAQ:) had asked Johansson to continue in the role to oversee its now-completed $39 billion acquisition of rare diseases medicines maker Alexion (NASDAQ:).
“The Board believes it would be in the best interests of shareholders for Mr Johansson to seek re-election at the AGM in April 2022 and continue to serve as Chair for one further year,” AstraZeneca said in a statement.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
Be the first to comment